Wstęp
Ta strona zawiera kompleksową analizę znanej historii wykorzystywania informacji poufnych w firmie John L Bishop. Insiderzy to członkowie kadry kierowniczej, dyrektorzy lub znaczący inwestorzy w spółce. Dokonywanie transakcji w ich firmach w oparciu o określone, niepubliczne informacje jest nielegalne. Nie oznacza to, że dokonywanie jakichkolwiek transakcji we własnych firmach jest nielegalne. Muszą jednak zgłaszać wszystkie transakcje do SEC za pośrednictwem formularza 4. Pomimo tych ograniczeń badania akademickie sugerują, że insiderzy – ogólnie rzecz biorąc – mają tendencję do osiągania lepszych wyników na rynku w swoich własnych firmach.
Średnia rentowność handlu
Średnia rentowność handlu to średni zwrot ze wszystkich zakupów na otwartym rynku dokonanych przez osobę mającą dostęp do informacji poufnych w ciągu ostatnich trzech lat. Aby to obliczyć, badamy każdy nieplanowany zakup na otwartym rynku dokonany przez insidera, z wyłączeniem wszystkich transakcji oznaczonych jako część planu handlowego 10b5-1. Następnie obliczamy średnią wydajność tych transakcji w ciągu 3, 6 i 12 miesięcy, uśredniając każdy z tych okresów, aby wygenerować ostateczny wskaźnik wydajności dla każdej transakcji. Na koniec uśredniamy wszystkie wskaźniki wydajności, aby obliczyć wskaźnik wydajności dla insidera. Na tej liście znajdują się wyłącznie insiderzy, którzy dokonali co najmniej trzech transakcji w ciągu ostatnich dwóch lat.
Jeśli rentowność handlu insiderów jest oznaczona notką„nie dotyczy”, oznacza to, że insider albo nie dokonał żadnych zakupów na otwartym rynku w ciągu ostatnich trzech lat, albo transakcje, których dokonał, są zbyt nowe, aby obliczyć wiarygodny wskaźnik wydajności.
Częstotliwość aktualizacji: codziennie
Spółki posiadające zgłoszone stanowiska osób mających dostęp do poufnych informacji
Z dokumentów SEC wynika, że John L Bishop zgłosił udziały lub transakcje w następujących spółkach:
| Papier wartościowy | Nazwa | Najnowsze raporty dotyczące udziałów |
|---|---|---|
| US:VCYT / Veracyte, Inc. | Director | 33 125 |
| US:CPHD / Cepheid | Chairman of the Board and CEO, Director | 0 |
| US:CPTS / CENTURY PLAZA TOWERS 2019-CPT CPTS 2019 CPT A 144A | Director | 0 |
Jak interpretować wykresy
Poniższe wykresy przedstawiają notowania akcji papierów wartościowych po każdej niezaplanowanej transakcji na otwartym rynku dokonanej przez John L Bishop. Nieplanowane transakcje to transakcje, które nie zostały dokonane w ramach planu handlowego 10b5-1. Notowania akcji przedstawiono na wykresie jako skumulowaną procentową zmianę ceny akcji. Na przykład, jeśli 1 stycznia 2019 r. dokonano transakcji poufnej, wykres pokaże dzienną procentową zmianę papieru wartościowego do dnia dzisiejszego. Jeżeli cena akcji wzrosłaby w tym czasie z 10 do 15 dolarów, skumulowana procentowa zmiana ceny akcji wyniosłaby 50%. Zmiana ceny z 10$ na 20$ będzie wynosić 100%, a zmiana ceny z 10$ na 5$ będzie wynosić -50%.
Ostatecznie staramy się określić, jak blisko transakcje insiderów korelują z nadmiernymi zwrotami (dodatnimi lub ujemnymi) z ceny akcji, aby sprawdzić, czy insider dostosowuje swoje transakcje w taki sposób, aby czerpać korzyści z informacji poufnych. Rozważmy sytuację, w której zrobił to ktoś z wewnątrz. W tej sytuacji oczekiwalibyśmy albo (a) dodatnich zwrotów po zakupach, albo (b) ujemnych zwrotów po sprzedaży. W przypadku (a) wykres ZAKUPU pokazywałby serię krzywych nachylonych w górę, wskazujących dodatnie zwroty po każdej transakcji zakupu. W przypadku (b) wykres SPRZEDAŻ pokazywałby serię krzywych o nachyleniu w dół, wskazujących ujemne zwroty po każdej transakcji sprzedaży.
Samo to jednak nie wystarczy, aby wyciągnąć wnioski. Gdyby np. cena akcji spółki przez wiele lat rosła niecyklicznie, to spodziewalibyśmy się, że wszystkie wykresy po zakupie będą wykazywały tendencję wzrostową. Podobnie niecykliczne spadki na przestrzeni wielu lat spowodowałyby spadek linii na wykresie po transakcjach. Żaden z tych wykresów nie sugeruje wykorzystywania informacji poufnych.
Najsilniejszym wskaźnikiem byłaby sytuacja, gdy cena akcji miała charakter wyjątkowo cykliczny, a na wykresie KUPNO występowały zarówno pozytywne sygnały na wykresie KUPNA, jak i negatywne na wykresie SPRZEDAŻY. Sytuacja ta wysoce sugerowałaby osobę mającą dostęp do informacji poufnych, która wykorzystywała transakcje w celu uzyskania korzyści finansowej.
Zakupy insidera VCYT / Veracyte, Inc. – krótkoterminowa analiza zysków
W tej części analizujemy rentowność każdego nieplanowanego zakupu od poufnych informacji na otwartym rynku dokonanego w VCYT / Veracyte, Inc.. Analiza ta pomaga zrozumieć, czy insider konsekwentnie generuje nietypowe zyski i czy warto ją śledzić. Analiza ta obejmuje okres jednego roku po każdej transakcji, a wyniki mają charakter teoretyczny .
Poniższa tabela przedstawia najnowsze zakupy na otwartym rynku, które nie były częścią planu handlu automatycznego.
| Data transakcji | Ticker | Insider | Zgłoszone Akcje |
Zgłoszona Cena |
Skorygowane Akcje |
Skorygowana Cena |
Podstawa kalkulacji kosztów | Dni do maks |
Cena maks |
Maks Zysk ($) |
Maksymalny zwrot (%) |
|---|---|---|---|---|---|---|---|
| Nie znane są żadne nieplanowane transakcje na otwarttm rynku dla tej kombinacji insidera i papieru wartościowego |
Cena skorygowana to cena skorygowana o podział. Akcje skorygowane to akcje skorygowane o podział.
Sprzedaż insidera VCYT / Veracyte, Inc. — analiza strat krótkoterminowych
W tej sekcji analizujemy możliwość uniknięcia krótkoterminowych strat w wyniku każdej nieplanowanej sprzedaży poufnych informacji na otwartym rynku dokonanej w VCYT / Veracyte, Inc.. Konsekwentny wzorzec unikania strat może sugerować, że przyszłe transakcje sprzedaży mogą przewidywać spadki cen. Analiza ta obejmuje okres jednego roku po każdej transakcji, a wyniki mają charakter teoretyczny .
Poniższa tabela przedstawia najnowsze sprzedaże na otwartym rynku, które nie były częścią planu handlu automatycznego.
| Data transakcji | Ticker | Insider | Zgłoszone Akcje |
Zgłoszona Cena |
Skorygowane Akcje |
Skorygowana Cena |
Podstawa kalkulacji kosztów | Dni do min |
Cena min |
Uniknięta maksymalna strata ($) |
Uniknięta Maksymalna strata (%) |
|---|---|---|---|---|---|---|---|
| Nie znane są żadne nieplanowane transakcje na otwarttm rynku dla tej kombinacji insidera i papieru wartościowego |
Cena skorygowana to cena skorygowana o podział. Akcje skorygowane to akcje skorygowane o podział.
Historia handlu insiderów
Ta tabela przedstawia pełną listę transakcji insiderów dokonanych przez firmę John L Bishop ujawnioną Komisji Papierów Wartościowych (SEC).
| Data pliku | Data trans | Formularz | Ticker | Bezpieczeństwo | Kod | Akcje | Pozostałe akcje | Zmiana procent |
Cena udziału |
Wartość trans |
Pozostała Wartość |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-07-19 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
S - Sale | X | -10 000 | 33 125 | -23,19 | 30,50 | -305 000 | 1 010 312 |
| 2023-07-19 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
M - Exercise | X | 10 000 | 43 125 | 30,19 | 6,37 | 63 700 | 274 706 |
| 2023-07-19 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
S - Sale | X | -10 000 | 33 125 | -23,19 | 30,00 | -300 002 | 993 757 |
| 2023-07-19 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
M - Exercise | X | 10 000 | 43 125 | 30,19 | 6,37 | 63 700 | 274 706 |
| 2023-06-13 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
A - Award | 9 674 | 33 125 | 41,25 | ||||
| 2022-06-16 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
A - Award | 14 731 | 23 451 | 168,93 | ||||
| 2021-06-10 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
A - Award | 8 720 | 8 720 | |||||
| 2020-06-09 |
|
4 | VCYT |
VERACYTE, INC.
Stock Option (right to buy) |
A - Award | 10 000 | 10 000 | |||||
| 2019-06-13 |
|
4 | VCYT |
VERACYTE, INC.
Stock Option (right to buy) |
A - Award | 10 000 | 10 000 | |||||
| 2018-06-07 |
|
4 | VCYT |
VERACYTE, INC.
Stock Option (right to buy) |
A - Award | 10 000 | 10 000 | |||||
| 2017-06-07 |
|
4 | VCYT |
VERACYTE, INC.
Stock Option (right to buy) |
A - Award | 10 000 | 10 000 | |||||
| 2016-11-07 |
|
4 | CPHD |
CEPHEID
Employee Stock Option (Right to Buy) |
D - Sale to Issuer | -150 000 | 0 | -100,00 | ||||
| 2016-11-07 |
|
4 | CPHD |
CEPHEID
Employee Stock Option (Right to Buy) |
D - Sale to Issuer | -205 000 | 0 | -100,00 | ||||
| 2016-11-07 |
|
4 | CPHD |
CEPHEID
Employee Stock Option (Right to Buy) |
D - Sale to Issuer | -176 250 | 0 | -100,00 | ||||
| 2016-11-07 |
|
4 | CPHD |
CEPHEID
Employee Stock Option (Right to Buy) |
D - Sale to Issuer | -176 250 | 0 | -100,00 | ||||
| 2016-11-07 |
|
4 | CPHD |
CEPHEID
Employee Stock Option (Right to Buy) |
D - Sale to Issuer | -153 750 | 0 | -100,00 | ||||
| 2016-11-07 |
|
4 | CPHD |
CEPHEID
Employee Stock Option (Right to Buy) |
D - Sale to Issuer | -180 000 | 0 | -100,00 | ||||
| 2016-11-07 |
|
4 | CPHD |
CEPHEID
Employee Stock Option (Right to Buy) |
D - Sale to Issuer | -175 000 | 0 | -100,00 | ||||
| 2016-11-07 |
|
4 | CPHD |
CEPHEID
Performance Stock Unit |
D - Sale to Issuer | -75 000 | 0 | -100,00 | ||||
| 2016-11-07 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
D - Sale to Issuer | -9 751 | 0 | -100,00 | ||||
| 2016-11-07 |
|
4 | CPHD |
CEPHEID
Common Stock |
D - Sale to Issuer | -83 092 | 0 | -100,00 | ||||
| 2016-10-31 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
M - Exercise | -1 219 | 2 438 | -33,33 | ||||
| 2016-10-31 |
|
4 | CPHD |
CEPHEID
Common Stock |
F - Taxes | -637 | 83 009 | -0,76 | 52,76 | -33 608 | 4 379 555 | |
| 2016-10-31 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 1 219 | 83 646 | 1,48 | ||||
| 2016-10-31 |
|
4 | CPHD |
CEPHEID
Common Stock |
F - Taxes | -751 | 82 427 | -0,90 | 52,92 | -39 743 | 4 362 037 | |
| 2016-10-24 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
M - Exercise | -1 219 | 7 313 | -14,29 | ||||
| 2016-10-24 |
|
4 | CPHD |
CEPHEID
Common Stock |
F - Taxes | -637 | 83 178 | -0,76 | 52,80 | -33 634 | 4 391 798 | |
| 2016-10-24 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 1 219 | 83 815 | 1,48 | ||||
| 2016-08-02 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
M - Exercise | -1 218 | 3 657 | -24,98 | ||||
| 2016-08-02 |
|
4 | CPHD |
CEPHEID
Common Stock |
F - Taxes | -636 | 82 596 | -0,76 | 35,33 | -22 470 | 2 918 117 | |
| 2016-08-02 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 1 218 | 83 232 | 1,49 | ||||
| 2016-07-28 |
|
4 | CPHD |
CEPHEID
Common Stock |
F - Taxes | -750 | 81 862 | -0,91 | 33,10 | -24 825 | 2 709 632 | |
| 2016-07-28 |
|
4 | CPHD |
CEPHEID
Performance Stock Unit |
A - Award | 75 000 | 75 000 | |||||
| 2016-07-25 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
M - Exercise | -1 218 | 8 532 | -12,49 | ||||
| 2016-07-25 |
|
4 | CPHD |
CEPHEID
Common Stock |
F - Taxes | -636 | 82 612 | -0,76 | 32,90 | -20 924 | 2 717 935 | |
| 2016-07-25 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 1 218 | 83 248 | 1,48 | ||||
| 2016-06-20 |
|
4 | VCYT |
VERACYTE, INC.
Stock Option (Right to Buy) |
A - Award | 10 000 | 10 000 | |||||
| 2016-05-03 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
M - Exercise | -1 219 | 4 875 | -20,00 | ||||
| 2016-05-03 |
|
4 | CPHD |
CEPHEID
Common Stock |
F - Taxes | -637 | 82 030 | -0,77 | 28,54 | -18 180 | 2 341 136 | |
| 2016-05-03 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 1 219 | 82 667 | 1,50 | ||||
| 2016-04-29 |
|
4 | CPHD |
CEPHEID
Common Stock |
F - Taxes | -3 001 | 81 448 | -3,55 | 36,57 | -109 747 | 2 978 553 | |
| 2016-04-27 |
|
4 | CPHD |
CEPHEID
Employee Stock Option (Right to Buy) |
A - Award | 150 000 | 150 000 | |||||
| 2016-04-27 |
|
4 | CPHD |
CEPHEID
Employee Stock Option (Right to Buy) |
M - Exercise | X | -110 000 | 0 | -100,00 | |||
| 2016-04-27 |
|
4 | CPHD |
CEPHEID
Common Stock |
S - Sale | X | -110 000 | 84 449 | -56,57 | 35,50 | -3 904 824 | 2 997 804 |
| 2016-04-27 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | X | 110 000 | 194 449 | 130,26 | 8,43 | 927 300 | 1 639 205 |
| 2016-04-25 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
M - Exercise | -1 063 | 0 | -100,00 | ||||
| 2016-04-25 |
|
4 | CPHD |
CEPHEID
Common Stock |
F - Taxes | -400 | 84 449 | -0,47 | 35,34 | -14 136 | 2 984 428 | |
| 2016-04-25 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 1 063 | 84 849 | 1,27 | ||||
| 2016-04-25 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
M - Exercise | -1 219 | 9 750 | -11,11 | ||||
| 2016-04-25 |
|
4 | CPHD |
CEPHEID
Common Stock |
F - Taxes | -459 | 83 786 | -0,54 | 34,98 | -16 056 | 2 930 834 | |
| 2016-04-25 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 1 219 | 84 245 | 1,47 | ||||
| 2016-02-02 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
M - Exercise | -1 219 | 6 094 | -16,67 | ||||
| 2016-02-02 |
|
4 | CPHD |
CEPHEID
Common Stock |
F - Taxes | -534 | 83 026 | -0,64 | 29,45 | -15 726 | 2 445 116 | |
| 2016-02-02 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 1 219 | 83 560 | 1,48 | ||||
| 2016-01-25 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
M - Exercise | -1 062 | 1 063 | -49,98 | ||||
| 2016-01-25 |
|
4 | CPHD |
CEPHEID
Common Stock |
F - Taxes | -437 | 82 199 | -0,53 | 32,93 | -14 390 | 2 706 813 | |
| 2016-01-25 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 1 062 | 82 636 | 1,30 | ||||
| 2016-01-25 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
M - Exercise | -1 219 | 10 969 | -10,00 | ||||
| 2016-01-25 |
|
4 | CPHD |
CEPHEID
Common Stock |
F - Taxes | -534 | 81 574 | -0,65 | 32,68 | -17 451 | 2 665 838 | |
| 2016-01-25 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 1 219 | 82 108 | 1,51 | ||||
| 2015-11-02 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
M - Exercise | -1 219 | 7 313 | -14,29 | ||||
| 2015-11-02 |
|
4 | CPHD |
CEPHEID
Common Stock |
F - Taxes | -637 | 80 889 | -0,78 | 34,27 | -21 830 | 2 772 066 | |
| 2015-11-02 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 1 219 | 81 526 | 1,52 | ||||
| 2015-10-28 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
M - Exercise | -1 063 | 2 125 | -33,34 | ||||
| 2015-10-28 |
|
4 | CPHD |
CEPHEID
Common Stock |
F - Taxes | -555 | 80 307 | -0,69 | 30,87 | -17 133 | 2 479 077 | |
| 2015-10-28 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 1 063 | 80 862 | 1,33 | ||||
| 2015-10-23 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
M - Exercise | -1 219 | 12 188 | -9,09 | ||||
| 2015-10-23 |
|
4 | CPHD |
CEPHEID
Common Stock |
F - Taxes | -637 | 79 799 | -0,79 | 30,02 | -19 123 | 2 395 566 | |
| 2015-10-23 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 1 219 | 80 436 | 1,54 | ||||
| 2015-07-31 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
M - Exercise | -1 218 | 8 532 | -12,49 | ||||
| 2015-07-31 |
|
4 | CPHD |
CEPHEID
Common Stock |
F - Taxes | -636 | 79 113 | -0,80 | 55,71 | -35 432 | 4 407 385 | |
| 2015-07-31 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 1 218 | 79 749 | 1,55 | ||||
| 2015-07-28 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
M - Exercise | -1 062 | 3 188 | -24,99 | ||||
| 2015-07-28 |
|
4 | CPHD |
CEPHEID
Common Stock |
F - Taxes | -555 | 78 531 | -0,70 | 56,26 | -31 224 | 4 418 154 | |
| 2015-07-28 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 1 062 | 79 086 | 1,36 | ||||
| 2015-07-23 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
M - Exercise | -1 218 | 13 407 | -8,33 | ||||
| 2015-07-23 |
|
4 | CPHD |
CEPHEID
Common Stock |
F - Taxes | -636 | 78 024 | -0,81 | 62,93 | -40 023 | 4 910 050 | |
| 2015-07-23 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 1 218 | 78 660 | 1,57 | ||||
| 2015-05-01 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
M - Exercise | -1 219 | 9 750 | -11,11 | ||||
| 2015-05-01 |
|
4 | CPHD |
CEPHEID
Common Stock |
F - Taxes | -637 | 77 442 | -0,82 | 56,71 | -36 124 | 4 391 736 | |
| 2015-05-01 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 1 219 | 78 079 | 1,59 | ||||
| 2015-04-28 |
|
4 | CPHD |
CEPHEID
Non-qualified option (Right to Buy) |
A - Award | 205 000 | 205 000 | |||||
| 2015-04-28 |
|
4 | CPHD |
CEPHEID
Common Stock |
A - Award | 23 000 | 76 860 | 42,70 | ||||
| 2015-04-28 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
M - Exercise | -1 563 | 0 | -100,00 | ||||
| 2015-04-28 |
|
4 | CPHD |
CEPHEID
Common Stock |
F - Taxes | -816 | 53 860 | -1,49 | 58,97 | -48 120 | 3 176 124 | |
| 2015-04-28 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 1 563 | 54 676 | 2,94 | ||||
| 2015-04-28 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
M - Exercise | -1 063 | 4 250 | -20,01 | ||||
| 2015-04-28 |
|
4 | CPHD |
CEPHEID
Common Stock |
F - Taxes | -555 | 53 113 | -1,03 | 58,97 | -32 728 | 3 132 074 | |
| 2015-04-28 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 1 063 | 53 668 | 2,02 | ||||
| 2015-04-23 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
M - Exercise | -4 875 | 14 625 | -25,00 | ||||
| 2015-04-23 |
|
4 | CPHD |
CEPHEID
Common Stock |
F - Taxes | -2 544 | 52 605 | -4,61 | 53,92 | -137 172 | 2 836 462 | |
| 2015-04-23 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 4 875 | 55 149 | 9,70 | ||||
| 2015-04-21 |
|
4 | CPHD |
CEPHEID
Non-qualified Stock Option (Right to Buy) |
M - Exercise | X | -100 000 | 0 | -100,00 | |||
| 2015-04-21 |
|
4 | CPHD |
CEPHEID
Common Stock |
S - Sale | X | -1 200 | 50 274 | -2,33 | 55,98 | -67 176 | 2 814 359 |
| 2015-04-21 |
|
4 | CPHD |
CEPHEID
Common Stock |
S - Sale | X | -98 800 | 51 474 | -65,75 | 55,19 | -5 452 752 | 2 840 840 |
| 2015-04-21 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | X | 100 000 | 150 274 | 198,91 | 19,85 | 1 985 000 | 2 982 939 |
| 2015-03-30 |
|
4/A | CPHD |
CEPHEID
Non-qualified Stock Option (Right to Buy) |
M - Exercise | X | -25 000 | 100 000 | -20,00 | |||
| 2015-03-30 |
|
4/A | CPHD |
CEPHEID
Common Stock |
S - Sale | X | -25 000 | 50 274 | -33,21 | 60,00 | -1 500 000 | 3 016 440 |
| 2015-03-30 |
|
4/A | CPHD |
CEPHEID
Common Stock |
M - Exercise | X | 25 000 | 75 274 | 49,73 | 19,85 | 496 250 | 1 494 189 |
| 2015-03-23 |
|
4 | CPHD |
CEPHEID
Non-qualified Stock Option (Right to Buy) |
M - Exercise | X | -17 486 | 107 514 | -13,99 | |||
| 2015-03-23 |
|
4 | CPHD |
CEPHEID
Common Stock |
S - Sale | X | -17 486 | 50 274 | -25,81 | 60,00 | -1 049 160 | 3 016 440 |
| 2015-03-23 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | X | 17 486 | 67 760 | 34,78 | 19,85 | 347 097 | 1 345 036 |
| 2015-02-02 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
M - Exercise | -1 219 | 10 969 | -10,00 | ||||
| 2015-02-02 |
|
4 | CPHD |
CEPHEID
Common Stock |
F - Taxes | -448 | 50 274 | -0,88 | 54,09 | -24 232 | 2 719 321 | |
| 2015-02-02 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 1 219 | 50 621 | 2,47 | ||||
| 2015-01-27 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
M - Exercise | -1 562 | 1 563 | -49,98 | ||||
| 2015-01-27 |
|
4 | CPHD |
CEPHEID
Common Stock |
F - Taxes | -658 | 49 402 | -1,31 | 55,02 | -36 203 | 2 718 098 | |
| 2015-01-27 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 1 562 | 50 060 | 3,22 | ||||
| 2015-01-27 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
M - Exercise | -1 062 | 5 313 | -16,66 | ||||
| 2015-01-27 |
|
4 | CPHD |
CEPHEID
Common Stock |
F - Taxes | -390 | 48 498 | -0,80 | 55,02 | -21 458 | 2 668 360 | |
| 2015-01-27 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 1 062 | 48 888 | 2,22 | ||||
| 2014-12-03 |
|
4 | VCYT |
VERACYTE, INC.
Stock option (right to buy) |
A - Award | 35 000 | 35 000 | |||||
| 2014-10-31 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
M - Exercise | -1 219 | 12 188 | -9,09 | ||||
| 2014-10-31 |
|
4 | CPHD |
CEPHEID
Common Stock |
F - Taxes | -637 | 47 826 | -1,31 | 51,90 | -33 060 | 2 482 169 | |
| 2014-10-31 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 1 219 | 48 463 | 2,58 | ||||
| 2014-10-28 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
M - Exercise | -1 563 | 3 125 | -33,34 | ||||
| 2014-10-28 |
|
4 | CPHD |
CEPHEID
Common Stock |
F - Taxes | -816 | 47 244 | -1,70 | 50,08 | -40 865 | 2 365 980 | |
| 2014-10-28 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 1 563 | 48 060 | 3,36 | ||||
| 2014-10-28 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
M - Exercise | -1 063 | 6 375 | -14,29 | ||||
| 2014-10-28 |
|
4 | CPHD |
CEPHEID
Common Stock |
F - Taxes | -555 | 46 497 | -1,18 | 50,08 | -27 794 | 2 328 570 | |
| 2014-10-28 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 1 063 | 47 052 | 2,31 | ||||
| 2014-07-31 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
M - Exercise | -1 218 | 13 407 | -8,33 | ||||
| 2014-07-31 |
|
4 | CPHD |
CEPHEID
Common Stock |
F - Taxes | -636 | 45 868 | -1,37 | 39,50 | -25 122 | 1 811 786 | |
| 2014-07-31 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 1 218 | 46 504 | 2,69 | ||||
| 2014-07-28 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
M - Exercise | -1 562 | 4 688 | -24,99 | ||||
| 2014-07-28 |
|
4 | CPHD |
CEPHEID
Common Stock |
F - Taxes | -816 | 45 286 | -1,77 | 39,47 | -32 208 | 1 787 438 | |
| 2014-07-28 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 1 562 | 46 102 | 3,51 | ||||
| 2014-07-28 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
M - Exercise | -1 062 | 7 438 | -12,49 | ||||
| 2014-07-28 |
|
4 | CPHD |
CEPHEID
Common Stock |
F - Taxes | -555 | 44 540 | -1,23 | 40,55 | -22 505 | 1 806 097 | |
| 2014-07-28 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 1 062 | 45 095 | 2,41 | ||||
| 2014-04-30 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
M - Exercise | -4 875 | 14 625 | -25,00 | ||||
| 2014-04-30 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
M - Exercise | -1 250 | 0 | -100,00 | ||||
| 2014-04-30 |
|
4 | CPHD |
CEPHEID
Common Stock |
F - Taxes | -2 544 | 44 033 | -5,46 | 42,14 | -107 204 | 1 855 551 | |
| 2014-04-30 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 4 875 | 46 577 | 11,69 | ||||
| 2014-04-30 |
|
4 | CPHD |
CEPHEID
Common Stock |
F - Taxes | -653 | 41 702 | -1,54 | 42,14 | -27 517 | 1 757 322 | |
| 2014-04-30 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 1 250 | 42 355 | 3,04 | ||||
| 2014-04-25 |
|
4 | CPHD |
CEPHEID
Non-Qualified Stock Option (right to buy) |
M - Exercise | -29 775 | 0 | -100,00 | ||||
| 2014-04-25 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
M - Exercise | -1 563 | 6 250 | -20,01 | ||||
| 2014-04-25 |
|
4 | CPHD |
CEPHEID
Common Stock |
S - Sale | -8 638 | 41 105 | -17,37 | 42,01 | -362 889 | 1 726 854 | |
| 2014-04-25 |
|
4 | CPHD |
CEPHEID
Common Stock |
S - Sale | -21 137 | 49 743 | -29,82 | 43,09 | -910 785 | 2 143 406 | |
| 2014-04-25 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 29 775 | 70 880 | 72,44 | 11,94 | 355 514 | 846 307 | |
| 2014-04-25 |
|
4 | CPHD |
CEPHEID
Common Stock |
F - Taxes | -816 | 41 105 | -1,95 | 42,02 | -34 288 | 1 727 232 | |
| 2014-04-25 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 1 563 | 41 921 | 3,87 | ||||
| 2014-04-25 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
M - Exercise | -1 063 | 8 500 | -11,12 | ||||
| 2014-04-25 |
|
4 | CPHD |
CEPHEID
Non-Qualified Stock Option (right to buy) |
M - Exercise | -36 907 | 29 775 | -55,35 | ||||
| 2014-04-25 |
|
4 | CPHD |
CEPHEID
Common Stock |
F - Taxes | -555 | 40 358 | -1,36 | 43,55 | -24 170 | 1 757 591 | |
| 2014-04-25 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 1 063 | 40 913 | 2,67 | ||||
| 2014-04-25 |
|
4 | CPHD |
CEPHEID
Common Stock |
S - Sale | -30 000 | 39 850 | -42,95 | 43,37 | -1 301 010 | 1 728 175 | |
| 2014-04-25 |
|
4 | CPHD |
CEPHEID
Common Stock |
S - Sale | -6 907 | 69 850 | -9,00 | 44,62 | -308 163 | 3 116 435 | |
| 2014-04-25 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 36 907 | 76 757 | 92,61 | 11,94 | 440 670 | 916 479 | |
| 2014-04-25 |
|
4 | CPHD |
CEPHEID
Non-Qualified Stock Option (right to buy) |
M - Exercise | -40 969 | 66 682 | -38,06 | ||||
| 2014-04-25 |
|
4 | CPHD |
CEPHEID
Common Stock |
S - Sale | -40 969 | 39 850 | -50,69 | 45,06 | -1 846 014 | 1 795 593 | |
| 2014-04-25 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 40 969 | 80 819 | 102,81 | 11,94 | 489 170 | 964 979 | |
| 2014-04-23 |
|
4 | CPHD |
CEPHEID
Non-Qualified Stock Option (right to buy) |
M - Exercise | -42 349 | 107 651 | -28,23 | ||||
| 2014-04-23 |
|
4 | CPHD |
CEPHEID
Common Stock |
S - Sale | -42 349 | 39 850 | -51,52 | 46,11 | -1 952 573 | 1 837 352 | |
| 2014-04-23 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 42 349 | 82 199 | 106,27 | 11,94 | 505 647 | 981 456 | |
| 2014-04-23 |
|
4 | CPHD |
CEPHEID
Non-Qualified Stock Option (right to buy) |
A - Award | 176 250 | 176 250 | |||||
| 2014-04-23 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
A - Award | 19 500 | 19 500 | |||||
| 2014-02-03 |
|
4 | CPHD |
CEPHEID
Non-qualified stock option (right to buy) |
M - Exercise | X | -50 000 | 0 | -100,00 | |||
| 2014-02-03 |
|
4 | CPHD |
CEPHEID
Non-qualified stock option (right to buy) |
M - Exercise | X | -100 000 | 0 | -100,00 | |||
| 2014-02-03 |
|
4 | CPHD |
CEPHEID
Common Stock |
S - Sale | X | -25 000 | 39 176 | -38,96 | 51,25 | -1 281 250 | 2 007 770 |
| 2014-02-03 |
|
4 | CPHD |
CEPHEID
Common Stock |
S - Sale | X | -125 000 | 64 176 | -66,08 | 50,55 | -6 318 750 | 3 244 097 |
| 2014-02-03 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | X | 50 000 | 189 176 | 35,93 | 9,08 | 453 750 | 1 716 772 |
| 2014-02-03 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | X | 100 000 | 139 176 | 255,26 | 7,35 | 735 000 | 1 022 944 |
| 2014-01-30 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
M - Exercise | -1 250 | 1 250 | -50,00 | ||||
| 2014-01-30 |
|
4 | CPHD |
CEPHEID
Common Stock |
F - Taxes | -653 | 39 070 | -1,64 | 46,56 | -30 404 | 1 819 099 | |
| 2014-01-30 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 1 250 | 39 723 | 3,25 | ||||
| 2014-01-28 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
M - Exercise | -1 562 | 7 813 | -16,66 | ||||
| 2014-01-28 |
|
4 | CPHD |
CEPHEID
Common Stock |
F - Taxes | -816 | 38 473 | -2,08 | 48,11 | -39 258 | 1 850 936 | |
| 2014-01-28 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 1 562 | 39 289 | 4,14 | ||||
| 2014-01-28 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
M - Exercise | -1 062 | 9 563 | -10,00 | ||||
| 2014-01-28 |
|
4 | CPHD |
CEPHEID
Common Stock |
F - Taxes | -555 | 37 727 | -1,45 | 48,11 | -26 701 | 1 815 046 | |
| 2014-01-28 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 1 062 | 38 282 | 2,85 | ||||
| 2014-01-21 |
|
4 | CPHD |
CEPHEID
Non-qualified stock option (right to buy) |
M - Exercise | X | -100 000 | 100 000 | -50,00 | |||
| 2014-01-21 |
|
4 | CPHD |
CEPHEID
Common Stock |
S - Sale | X | -25 000 | 37 220 | -40,18 | 49,75 | -1 243 750 | 1 851 695 |
| 2014-01-21 |
|
4 | CPHD |
CEPHEID
Common Stock |
S - Sale | X | -25 000 | 62 220 | -28,66 | 49,50 | -1 237 500 | 3 079 890 |
| 2014-01-21 |
|
4 | CPHD |
CEPHEID
Common Stock |
S - Sale | X | -25 000 | 87 220 | -22,28 | 49,25 | -1 231 250 | 4 295 585 |
| 2014-01-21 |
|
4 | CPHD |
CEPHEID
Common Stock |
S - Sale | X | -25 000 | 112 220 | -18,22 | 49,00 | -1 225 000 | 5 498 780 |
| 2014-01-21 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | X | 100 000 | 137 220 | 268,67 | 7,35 | 735 000 | 1 008 567 |
| 2013-10-30 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
M - Exercise | -1 250 | 2 500 | -33,33 | ||||
| 2013-10-30 |
|
4 | CPHD |
CEPHEID
Common Stock |
F - Taxes | -653 | 37 220 | -1,72 | 40,91 | -26 714 | 1 522 670 | |
| 2013-10-30 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 1 250 | 37 873 | 3,41 | ||||
| 2013-10-28 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
M - Exercise | -1 563 | 9 375 | -14,29 | ||||
| 2013-10-28 |
|
4 | CPHD |
CEPHEID
Common Stock |
F - Taxes | -816 | 36 623 | -2,18 | 40,48 | -33 032 | 1 482 499 | |
| 2013-10-28 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 1 563 | 37 439 | 4,36 | ||||
| 2013-10-28 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
M - Exercise | -1 063 | 10 625 | -9,09 | ||||
| 2013-10-28 |
|
4 | CPHD |
CEPHEID
Common Stock |
F - Taxes | -555 | 35 876 | -1,52 | 40,26 | -22 344 | 1 444 368 | |
| 2013-10-28 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 1 063 | 36 431 | 3,01 | ||||
| 2013-07-30 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
M - Exercise | -1 250 | 3 750 | -25,00 | ||||
| 2013-07-30 |
|
4 | CPHD |
CEPHEID
Common Stock |
F - Taxes | -653 | 35 263 | -1,82 | 34,44 | -22 489 | 1 214 458 | |
| 2013-07-30 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 1 250 | 35 916 | 3,61 | ||||
| 2013-07-25 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
M - Exercise | -1 562 | 10 938 | -12,50 | ||||
| 2013-07-25 |
|
4 | CPHD |
CEPHEID
Common Stock |
F - Taxes | -816 | 34 666 | -2,30 | 34,53 | -28 176 | 1 197 017 | |
| 2013-07-25 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 1 562 | 35 482 | 4,60 | ||||
| 2013-07-25 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
M - Exercise | -1 062 | 11 688 | -8,33 | ||||
| 2013-07-25 |
|
4 | CPHD |
CEPHEID
Common Stock |
F - Taxes | -555 | 33 920 | -1,61 | 33,80 | -18 759 | 1 146 496 | |
| 2013-07-25 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 1 062 | 34 475 | 3,18 | ||||
| 2013-06-07 |
|
4 | CPTS |
CONCEPTUS INC
Common Stock |
U - Other | -26 792 | 0 | -100,00 | 31,00 | -830 552 | ||
| 2013-06-07 |
|
4 | CPTS |
CONCEPTUS INC
Common Stock |
U - Other | -13 592 | 0 | -100,00 | 31,00 | -421 352 | ||
| 2013-05-01 |
|
4 | CPHD |
CEPHEID
Non-Qualified Stock Option (right to buy) |
A - Award | 176 250 | 176 250 | |||||
| 2013-05-01 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
A - Award | 19 500 | 19 500 | |||||
| 2013-05-01 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
M - Exercise | -1 250 | 5 000 | -20,00 | ||||
| 2013-05-01 |
|
4 | CPHD |
CEPHEID
Common Stock |
F - Taxes | -653 | 33 413 | -1,92 | 38,66 | -25 245 | 1 291 747 | |
| 2013-05-01 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 1 250 | 34 066 | 3,81 | ||||
| 2013-04-25 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
M - Exercise | -1 563 | 12 500 | -11,11 | ||||
| 2013-04-25 |
|
4 | CPHD |
CEPHEID
Common Stock |
F - Taxes | -816 | 32 816 | -2,43 | 38,42 | -31 351 | 1 260 791 | |
| 2013-04-25 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 1 563 | 33 632 | 4,87 | ||||
| 2013-04-25 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
M - Exercise | -4 250 | 12 750 | -25,00 | ||||
| 2013-04-25 |
|
4 | CPHD |
CEPHEID
Common Stock |
F - Taxes | -2 218 | 32 069 | -6,47 | 37,95 | -84 173 | 1 217 019 | |
| 2013-04-25 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 4 250 | 34 287 | 14,15 | ||||
| 2013-04-23 |
|
4 | CPHD |
CEPHEID
Non-qualified stock option (right to buy) |
M - Exercise | X | -134 799 | 0 | -100,00 | |||
| 2013-04-23 |
|
4 | CPHD |
CEPHEID
Common Stock |
S - Sale | X | -134 799 | 30 037 | -81,78 | 37,51 | -5 056 027 | 1 126 625 |
| 2013-04-23 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | X | 134 799 | 164 836 | 448,78 | 9,18 | 1 237 455 | 1 513 194 |
| 2013-01-30 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
M - Exercise | -1 250 | 6 250 | -16,67 | ||||
| 2013-01-30 |
|
4 | CPHD |
CEPHEID
Common Stock |
F - Taxes | -477 | 29 932 | -1,57 | 36,09 | -17 215 | 1 080 246 | |
| 2013-01-30 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 1 250 | 30 409 | 4,29 | ||||
| 2013-01-28 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
M - Exercise | -1 562 | 14 063 | -10,00 | ||||
| 2013-01-28 |
|
4 | CPHD |
CEPHEID
Common Stock |
F - Taxes | -685 | 29 159 | -2,30 | 37,83 | -25 914 | 1 103 085 | |
| 2013-01-28 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 1 562 | 29 844 | 5,52 | ||||
| 2012-10-31 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
M - Exercise | -1 250 | 7 500 | -14,29 | ||||
| 2012-10-31 |
|
4 | CPHD |
CEPHEID
Common Stock |
F - Taxes | -584 | 28 282 | -2,02 | 30,46 | -17 789 | 861 470 | |
| 2012-10-31 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 1 250 | 28 866 | 4,53 | ||||
| 2012-10-29 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
M - Exercise | -1 563 | 15 625 | -9,09 | ||||
| 2012-10-29 |
|
4 | CPHD |
CEPHEID
Common Stock |
F - Taxes | -730 | 27 616 | -2,58 | 31,10 | -22 703 | 858 858 | |
| 2012-10-29 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 1 563 | 28 346 | 5,84 | ||||
| 2012-07-31 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
M - Exercise | -1 250 | 8 750 | -12,50 | ||||
| 2012-07-31 |
|
4 | CPHD |
CEPHEID
Common Stock |
F - Taxes | -584 | 26 678 | -2,14 | 32,93 | -19 231 | 878 507 | |
| 2012-07-31 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 1 250 | 27 262 | 4,81 | ||||
| 2012-07-26 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
M - Exercise | -1 562 | 17 188 | -8,33 | ||||
| 2012-07-26 |
|
4 | CPHD |
CEPHEID
Common Stock |
F - Taxes | -730 | 26 012 | -2,73 | 32,51 | -23 732 | 845 650 | |
| 2012-07-26 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 1 562 | 26 742 | 6,20 | ||||
| 2012-07-03 |
|
4 | CPHD |
CEPHEID
Non-qualified stock option (right to buy) |
M - Exercise | X | -100 | 134 799 | -0,07 | |||
| 2012-07-03 |
|
4 | CPHD |
CEPHEID
Common Stock |
S - Sale | X | -100 | 25 180 | -0,40 | 46,00 | -4 600 | 1 158 280 |
| 2012-07-03 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | X | 100 | 25 280 | 0,40 | 9,18 | 918 | 232 070 |
| 2012-07-03 |
|
4 | CPHD |
CEPHEID
Non-qualified stock option (right to buy) |
M - Exercise | X | -40 101 | 134 899 | -22,91 | |||
| 2012-07-03 |
|
4 | CPHD |
CEPHEID
Common Stock |
S - Sale | X | -15 101 | 25 180 | -37,49 | 46,00 | -694 646 | 1 158 280 |
| 2012-07-03 |
|
4 | CPHD |
CEPHEID
Common Stock |
S - Sale | X | -25 000 | 40 281 | -38,30 | 45,50 | -1 137 500 | 1 832 786 |
| 2012-07-03 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | X | 40 101 | 65 281 | 159,26 | 9,18 | 368 127 | 599 280 |
| 2012-06-28 |
|
4 | CPHD |
CEPHEID
Non-qualified stock option (right to buy) |
M - Exercise | X | -25 000 | 175 000 | -12,50 | |||
| 2012-06-28 |
|
4 | CPHD |
CEPHEID
Common Stock |
S - Sale | X | -25 000 | 25 180 | -49,82 | 45,00 | -1 125 000 | 1 133 100 |
| 2012-06-28 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | X | 25 000 | 50 180 | 99,29 | 9,18 | 229 500 | 460 652 |
| 2012-05-24 |
|
4 | CPTS |
CONCEPTUS INC
Common Stock |
A - Award | 6 447 | 33 959 | 23,43 | ||||
| 2012-05-01 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
M - Exercise | -1 250 | 10 000 | -11,11 | ||||
| 2012-05-01 |
|
4 | CPHD |
CEPHEID
Common Stock |
F - Taxes | -459 | 25 180 | -1,79 | 38,50 | -17 672 | 969 430 | |
| 2012-05-01 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 1 250 | 25 639 | 5,13 | ||||
| 2012-04-26 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
M - Exercise | -6 250 | 18 750 | -25,00 | ||||
| 2012-04-26 |
|
4 | CPHD |
CEPHEID
Common Stock |
F - Taxes | -2 293 | 24 389 | -8,59 | 37,17 | -85 231 | 906 539 | |
| 2012-04-26 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 6 250 | 26 682 | 30,59 | ||||
| 2012-04-26 |
|
4 | CPHD |
CEPHEID
Non-Qualified Stock Option (right to buy) |
A - Award | 153 750 | 153 750 | |||||
| 2012-04-26 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units (right to buy) |
A - Award | 17 000 | 17 000 | |||||
| 2012-02-14 |
|
4 | CPHD |
CEPHEID
Employee Stock Option (right to buy) |
M - Exercise | X | -4 196 | 6 604 | -38,85 | |||
| 2012-02-14 |
|
4 | CPHD |
CEPHEID
Common Stock |
S - Sale | X | -4 196 | 18 373 | -18,59 | 32,50 | -136 370 | 597 122 |
| 2012-02-14 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 4 196 | 22 569 | 22,84 | 3,61 | 15 148 | 81 474 | |
| 2012-02-06 |
|
4 | CPHD |
CEPHEID
Non-Qualified Stock Option (right to buy) |
M - Exercise | -6 887 | 0 | -100,00 | ||||
| 2012-02-06 |
|
4 | CPHD |
CEPHEID
Common Stock |
S - Sale | -6 887 | 20 432 | -25,21 | 43,51 | -299 646 | 888 976 | |
| 2012-02-06 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 6 887 | 27 319 | 33,71 | 3,61 | 24 862 | 98 622 | |
| 2012-01-31 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
M - Exercise | -1 250 | 11 250 | -10,00 | ||||
| 2012-01-31 |
|
4 | CPHD |
CEPHEID
Common Stock |
F - Taxes | -523 | 20 432 | -2,50 | 43,14 | -22 562 | 881 436 | |
| 2012-01-31 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 1 250 | 20 955 | 6,34 |
